Efficacy of [18F]Florbetaben PET for Diagnosis of Cardiac AL Amyloidosis
Clinical trial NCT05184088 · COMPLETED
Trial details
- NCT number
- NCT05184088
- Sponsor
- Lantheus Germany GmbH
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-13
- Primary completion
- 2026-04-21
- Enrollment
- 244
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.